Vensica Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 3

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $19M

  • Investors
  • 9

Vensica General Information

Description

Developer of an ultrasound-based drug delivery system designed to treat overactive bladder (OAB). The company's system leverages the known properties of ultrasound, is needle-free, and is expected to not have any side effects, enabling medical professionals to safely and effectively deliver treatment to patients suffering from urinary overactive bladder.

Contact Information

Website
www.vensica.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Therapeutic Devices
Primary Office
  • HaGavish Street 4
  • Netanya 4250706
  • Israel
+972 000-000-0000

Vensica Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vensica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Nov-2021 $19M 000.00 Completed Generating Revenue
4. Corporate 11-Aug-2021 00.00 Completed Generating Revenue
3. Corporate 02-Oct-2017 000 00.00 Completed Generating Revenue
2. Angel (individual) 19-Jul-2016 $500K $500K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Vensica’s complete valuation and funding history, request access »

Vensica Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an ultrasound-based drug delivery system designed to treat overactive bladder (OAB). The company's system l
Drug Delivery
Netanya, Israel
3 As of 2022
000.00
0000000000 0 000.00

000000

o laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repr
0000 00000000
Princeton, NJ
000 As of 0000
00000
000000000 00000

000000

at nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa
00000000000 0000000
Milan, Italy
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vensica Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Urogen Pharma Formerly VC-backed Princeton, NJ 000 00000 000000000 00000
0000000000 Venture Capital-Backed Milan, Italy 00 000.00 00000000000 000.00
0000000 0000000000 Venture Capital-Backed Kirkland, WA 00 00000 00000000000 00000
00000000 (00000000 Venture Capital-Backed Paris, France 00 0000 00000000000 0000
000000000 00000000 Private Equity-Backed Irvine, CA 000 00000 0000000 0000 00000
You’re viewing 5 of 14 competitors. Get the full list »

Vensica Patents

Vensica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210052873-A1 System and method for ultrasonic bladder therapeutic agent delivery Active 01-Apr-2018 000000000
US-11529506-B2 System and method for ultrasonic bladder therapeutic agent delivery Active 01-Apr-2018 000000000 00
EP-3773262-A1 System and method for ultrasonic bladder therapeutic agent delivery Pending 01-Apr-2018 00000000000
AU-2019249430-A1 System and method for ultrasonic bladder therapeutic agent delivery Pending 01-Apr-2018 00000000000
CA-3095598-A1 System and method for ultrasonic bladder therapeutic agent delivery Pending 01-Apr-2018 A61M37/0092
To view Vensica’s complete patent history, request access »

Vensica Executive Team (1)

Name Title Board Seat Contact Info
Avner Geva Founder & Chief Executive Officer
To view Vensica’s complete executive team members history, request access »

Vensica Board Members (4)

Name Representing Role Since
Edit Goldberg Self Board Member 000 0000
Eran Feldhay MD Trendlines Board Member 000 0000
Nissim Darvish Ph.D Self Chairman 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Vensica Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vensica Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agriline Corporation Minority 000 0000 000000 0
Israel Biotech Fund Venture Capital Minority 000 0000 000000 0
Merz Pharma Corporation Minority 000 0000 000000 0
Cogentix Medical PE-Backed Company Minority 000 0000 000000 0
Israel Innovation Authority Government Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »